رجوع
نطاق اليوم
KWD 4.39
KWD 4.74
نطاق 52 أسبوعًا
KWD 2.19
KWD 8.80
حجم التداول
4,443,866
متوسط 50 يوم / 200 يوم
KWD 3.98
/
KWD 3.43
الإغلاق السابق
KWD 4.27
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.3 | 0.2 |
| P/B | 1.8 | 3.0 |
| ROE % | -60.3 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.1 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -190.45M
PEG of 0.07 suggests growth is underpriced
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-60.27%
ROIC-56.73%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.09
Current Ratio6.38
Interest Coverage-120.84
التقييم
P/E Ratio
-2.28
Forward P/EN/A
P/B Ratio1.83
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -223.12M |
| ROE | -60.27% | ROA | -67.52% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -190.45M |
| ROIC | -56.73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 6.38 |
| Interest Coverage | -120.84 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.28 | Forward P/E | N/A |
| P/B Ratio | 1.83 | P/S Ratio | N/A |
| PEG Ratio | 0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -37.48% | ||
| Market Cap | 508.10M | Enterprise Value | 455.42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -223.12M | -258.75M | -245.60M | -221.86M | -169.07M |
| EPS (Diluted) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 |
| Gross Profit | -11.03M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -228.52M | -273.21M | -259.66M | -224.34M | -167.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 330.45M | 527.70M | 566.34M | 551.81M | 497.02M |
| Total Liabilities | 53.23M | 64.47M | 73.77M | 62.12M | 42.30M |
| Shareholders' Equity | 277.22M | 463.23M | 492.57M | 489.69M | 454.72M |
| Total Debt | 24.88M | 25.50M | 25.04M | 22.87M | 22.60M |
| Cash & Equivalents | 77.56M | 163.64M | 55.90M | 140.52M | 232.69M |
| Current Assets | 192.73M | 378.18M | 378.22M | 364.06M | 392.06M |
| Current Liabilities | 30.21M | 40.68M | 48.51M | 39.17M | 22.17M |